UBS O'Connor’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,639
| Closed | -$177K | – | 384 |
|
|
2025
Q1 | $177K | Sell |
62,639
-66,351
| -51% | -$187K | 0.01% | 223 |
|
|
2024
Q4 | $887K | Buy |
128,990
+43,289
| +51% | +$298K | 0.02% | 235 |
|
|
2024
Q3 | $1.56M | Buy |
85,701
+8,861
| +12% | +$161K | 0.04% | 209 |
|
|
2024
Q2 | $1.46M | Buy |
76,840
+4,617
| +6% | +$87.7K | 0.04% | 235 |
|
|
2024
Q1 | $1.56M | Sell |
72,223
-20,975
| -23% | -$453K | 0.04% | 222 |
|
|
2023
Q4 | $1.62M | Sell |
93,198
-5,128
| -5% | -$89.1K | 0.05% | 206 |
|
|
2023
Q3 | $967K | Hold |
98,326
| – | – | 0.02% | 327 |
|
|
2023
Q2 | $541K | Buy |
98,326
+2,943
| +3% | +$16.2K | 0.01% | 431 |
|
|
2023
Q1 | $591K | Buy |
+95,383
| New | +$591K | 0.01% | 442 |
|
|
2022
Q4 | – | Sell |
-79,636
| Closed | -$786K | – | 272 |
|
|
2022
Q3 | $786K | Buy |
79,636
+50,820
| +176% | +$502K | 0.01% | 753 |
|
|
2022
Q2 | $341K | Buy |
+28,816
| New | +$341K | ﹤0.01% | 805 |
|